Owner AMGEN INC.

Inventors Wang, Hui-Ling; Norman, Mark H.; Kaller, Matthew; Zhong, Wenge; Rzasa, Robert; Nguyen, Thomas; Huang, Qi

Agent Davies Collison Cave

Pub. Number AU-A-2003273579

PCT Number PCT/US03/16941

PCT Pub. Number WO2003/101985

Priority 60/384,265 29.05.02 US; 10/446,440 27.05.03 US

Filing date 29 May 2003

Wipo publication date 19 December 2003

C07D 417/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 403/04 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 491/04 Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 417/04 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 409/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 513/04 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 031/505 - Pyrimidines

A61P 025/00 Drugs for disorders of the nervous system

A61P 035/00 Antineoplastic agents